A recent study highlights that a significant number of individuals may be measuring their blood pressure incorrectly. Research published in Hypertension, a journal of the American...
Alnylam Pharmaceuticals has announced the initiation of a Phase 3 cardiovascular outcomes trial for its hypertension therapy, zilebesiran, later this year. This decision comes despite recent...
